Human T Cells Require IL-2 but Not G1/S Transition to Acquire Susceptibility to Fas-Mediated Apoptosis

Journal of Immunology

Volumn 157, Issue 10, 1996, Pages 4309-4315

  Fournel, Sylvie ^a   Genestier, Laurent ^a   Robinet, Eric ^a   Flacher, Monique ^a   Revillard, Jean Pierre ^a,b  

^a UNIVERSITÉ LYON 1   (France)

^b EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2;

APOPTOSIS; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CYTOLOGY; DISEASE PREDISPOSITION; DRUG EFFECT; GENETICS; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; T LYMPHOCYTE;

ANTIGENS, CD95; APOPTOSIS; CELL CYCLE; CELLS, CULTURED; DISEASE SUSCEPTIBILITY; G1 PHASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; S PHASE; T-LYMPHOCYTES;

EID: 0030588710     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Lynch, D. H., F. Ramsdell, and M. R. Alderson. 1995. Fas and Fas L in the homeostatic regulation of immune responses. Immunol. Today 16:569.
2. Trauth, B. C., C. Klas, A. M. J. Peters, S. Matzku, P. Möller, W. Falk, K. M. Debatin, and P. H. Krammer. 1989. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245:301.
3. Itoh, N., S. Yonehara, A. Ishii, M. Yonehara, S. I. Mizushima, M. Sameshima, A. Hase, Y. Seto, and S. Nagata. 1991. The polypeptide encoded by cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233.
4. Smith, C. A., T. Farrah, and R. G. Goodwin. 1994. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation and death. Cell 76:959.
5. Armitage, R. J. 1994. Tumor necrosis factor receptor superfamily members and their ligands. Curr. Opin. Immunol. 6:407.
6. Suda, T., T. Takahashi, P. Golstein, and S. Nagata. 1993. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169.
7. Suda, T., and S. Nagata. 1994. Purification and characterization of the Fas-ligand that induces apoptosis. J. Exp. Med. 179:873.
8. Suda, T., T. Okazaki, Y. Naito, T. Yokota, N. Arai, S. Ozaki, K. Nakao, and S. Nagata. 1995. Expression of the Fas ligand in cells of T cell lineage. J. Immunol. 154:3806.
9. Kayagaki, N., A. Kawasaki, T. Ebata, H. Ohmoto, S. Ikeda, S. Inoue, K. Yoshino, K. Okumura, and H. Yagita. 1995. Metalloproteinase-mediated release of human Fas ligand. J. Exp. Med. 182:1777.
10. Mariani, S. M., B. Matiba, C. Baümler, and P. H. Krammer. 1995. Regulation of cell surface APO-1/Fas (CD95) ligand expression by metalloproteases. Eur. J. Immunol. 25:2303.
11. Watanabe-Fukanaga, R., C. I. Brannan, N. G. Coneland, N. A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314.
12. Ramsdell, F., M. S. Seaman, R. E. Miller, T. W. Tough, M. R. Alderson, and D. H. Lynch. 1994. gld/gld mice are unable to express a functional ligand for Fas. Eur. J. Immunol. 24:928.
13. Takahashi, T., M. Tanaka, C. I. Brannan, N. A. Jenkins, N. G. Copeland, T. Suda, and S. Nagata. 1994. Generalized lymphoproliferation disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969.
14. Rieux-Laucat, F., F. Le Deist, C. Hivroz, I. A. G. Robert, K. M. Debatin, A. Fischer, and J. P. de Villartay. 1995. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268:1347.
15. Fisher, G. H., F. J. Rosenberg, S E. Straus, J. K. Dale, L. A. Middelton, A. Y. Lin, W. Strober, M. J. Lenardo, and J. M. Puck. 1995. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:935.
16. Klas, C., K. M. Debatin, R. R. Jonker, and P. H. Krammer. 1993. Activation interferes with the Apo-1 pathway in mature human T cells. Int. Immunol. 5:625.
17. Lenardo, M. J. 1991. Interleukin-2 programs mouse αβ T lymphocytes for apoptosis. Nature 353:858.
18. + peripheral T cells responding to staphylococcal enterotoxin B in vivo. Eur. J. Immunol. 21:1963.
19. Zhu, L., and C. Anasetti. 1995. Cell cycle control apoptosis in human leukemic T cells. J. Immunol. 154:192.
20. Boehme, S. A., and M. J. Lenardo. 1993. Propriocidal apoptosis of mature T lymphocytes occurs at S phase of the cell cycle. Eur. J. Immunol. 23:1552.
21. Smith, K. A. 1984. Interleukin-2. Annu. Rev. Immunol. 2:319.
22. Fournel, S., L. Genestier, J. P. Rouault, G. Lizard, M. Flacher, O. Assossou, and J. P. Revillard. 1995. Apoptosis without decrease of cell DNA content. FEBS Lett. 367:188.
23. Zamzami, N., P. Marchetti, M. Castedo, D. Decaudin, A. Macho, T. Hirsh, S. A. Susin, P. X. Petit, B. Mignotte, and G. Kroemer. 1995. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J. Exp. Med. 182:367.
24. Zamzami, N., P. Marchetti, M. Castedo, C. Zanin, J.-L. Vayssière, P. X. Petit, and G. Kroemer. 1995. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J. Exp. Med. 181:1661.
25. Gorczyca, W., J. Gong, and Z. Darzynkiewicz. 1993. Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res. 53:1945.
26. Schreiber, S. L. 1992. Immunophilin-sensitive protein phosphatase action in cell signalling pathways. Cell 70:365.
27. 1 prolongation in mitogen-activated T lymphocytes. J. Immunol. 155:3418.
28. Depper, J. M., W. J. Leonard, T. A. Waldmann, and W. C. Green. 1983. Blockade of the interleukin-2 receptor by anti-Tac antibody: inhibition of human lymphocyte activation. J. Immunol. 131:690.
29. Leonard, W. J., E. W. Shores, and P. E. Lowe. 1995. Role of common cytokine receptor γ chain in cytokine signalling and lymphoid development. Immunol. Rev. 148:97.
30. Sigal, N. H., and F. J. Dumont. 1992. Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction. Annu. Rev. Immunol. 10:519.
31. Kneitz, B., T. Herrmann, S. Yonera, and A. Schimp. 1995. Normal clonal expansion but impaired Fas-mediated cell death and anergy induction in interleukin-2-deficient mice. Eur. J. Immunol. 25:2572.
32. Lenardo, M. J., S. Boehme, L. Chen, B. Combadiere, G. Fisher, M. Freedman, H. McFarland, C. Pelfrey, and L. Zhen. 1995. Autocrine feedback death and regulation of mature T lymphocyte antigen responses. Int. Rev. Immunol. 13:115.
33. Dhein, J., H. Walczak, C. Bäumler, K. M. Debatin, and P. H. Krammer. 1995. Autocrine T-cell suicide mediated by Apo-1/(Fas/CD95). Nature 373:438.
34. Brunner, T., R. J. Mogil, D. LaFace, N. Jin Yoo, A. Mahboubi, F. Echeverri, S. J. Martin, W. R. Force, D. H. Lynch, C. F. Ware, and D. R. Green. 1995. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373:441.
35. Ju, S. T., D. J. Panka, H. Cui, R. Ettinger, M. El-Khatib, D. H. Sherr, B. Z. Stanger, and A. M. Rothstein. 1995. Fas (CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 373:444.
36. Zhang, X., L. Giangreco, B. Broome, and S. L. Swain. 1994. TGF-β1 helps prevent apoptosis of CD4 effectors and helps drive them to memory cells. FASEB J. 8:A746.
37. Cerwenka, A., H. Kovar, O. Majdic, and W. Holter. 1996. Fas- and activation-induced apoptosis are reduced in human T cells preactivated in the presence of TGF-β1. J. Immunol. 156:459.
38. Kehrl, J. H., L. M. Wakefield, A. B. Roberts, S. Jakowlew, M. Alvarez-Mon, R. Derynck, M. B. Sporn, and A. S. Fauci. 1986. Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med. 163:1037.
39. Willerford, D. M., J. Chen, J. A. Ferry, L. Davidson, A. Ma, and F. W. Alt. 1995. Interleukin-2 receptor α chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3:521.
40. Cao, X., E. W. Shores, J. Hu-LI, M. R. Anver, B. L. Kelsall, S. M. Russell, J. Drago, M. Noguchi, A. Grinberg, E. T. Bloom, W. E. Paul, S. I. Katz, P. E. Love, and W. J. Leonard. 1995. Defective lymphoid development in mice lacking expression of the common cytokine receptor γ chain. Immunity 2:223.
41. Suzuki, H., T. M. Kündig, C. Furlonger, A. Wakeham, E. Timms, T. Matsuyama, R. Schmits, J. J. L. Simard, P. S. Ohashi, H. Griesser, T. Taniguchi, C. J. Paige, and T. W. Mak. 1995. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor β. Nature 268:1472.
42. Kündig, T. M., H. Schorle, M. F. Bachmann, H. Hengartner, R. M. Zinkernagel, and I. Horak. 1993. Immune responses in interleukin-2-deficient mice. Science 262:1059.
43. Alderson, M. R., R. J. Armitage, E. Maraskovsky, T. W. Tough, E. Roux, K. Schooley, F. Ramsdell, and D. H. Lynch. 1993. Fas transduces activation signals in normal human T lymphocytes. J. Exp. Med. 178:2231.